Home/Filings/4/0001474064-12-000011
4//SEC Filing

COTTRELL SANDRA 4

Accession 0001474064-12-000011

CIK 0000890465other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 4:07 PM ET

Size

5.9 KB

Accession

0001474064-12-000011

Insider Transaction Report

Form 4
Period: 2012-01-30
SANDRA COTTRELL
VP, Reg. Affairs & Drug Safety
Transactions
  • Award

    Stock Options

    2012-01-30+32,00032,000 total
    Exercise: $3.34Exp: 2020-02-19Common Stock (32,000 underlying)
Footnotes (1)
  • [F1]On February 19, 2010, the Reporting Person was granted options to purchase shares of Common Stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. On January 30, 2012, the performance criteria for 32,000 of these options had been satisfied because the Issuer's NDA was accepted by the FDA. These 32,000 options will vest and become exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant.

Issuer

NPS PHARMACEUTICALS INC

CIK 0000890465

Entity typeother

Related Parties

1
  • filerCIK 0001461361

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:07 PM ET
Size
5.9 KB